Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Sexual Dysfunction Among Adolescent and Young Adult Men Diagnosed with Cancer.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Rainer, Quinn Carroll; Dubin, Justin Michael; Balaji, Navin Chakravarthy; Troesch, Victoria; Terry, William; Monga, Varun; Clifford, Lindsey; Shoag, Jamie; Greer, Aubrey; Nackeeran, Sirpi; Rodriguez, Alejandro Aaron; Patel, Premal; Paz, Lisa; Kava, Bruce Richard; Alperstein, Warren; Pearlman, Amy Marcia; Ramasamy, Ranjith
- Source:
Journal of Adolescent & Young Adult Oncology; Feb2023, Vol. 12 Issue 1, p93-100, 8p
- Subject Terms:
- Additional Information
- Abstract:
Purpose: Adolescent and young adult (AYA) cancer patients frequently demonstrate sexual dysfunction; however, there is a lack of data quantifying the severity and frequency. Methods: Males aged 18–39 years, diagnosed with cancer of any kind and who were scheduled to begin, were actively receiving, or had completed cancer treatment within 6 months, were offered validated surveys during their oncology appointment. These surveys included the International Index of Erectile Function (IIEF-6), Masturbation Erection Index (MEI), 36-Item Short Form Survey, and 5-point Likert scales to assess their desire and ability to engage in sex and masturbation. Results: Forty subjects completed the IIEF survey with a mean score of 17.7 ± 11, erectile dysfunction (ED) prevalence accordingly was 58%. Thirty-eight subjects completed the MEI with a mean score of 25.3 ± 5.3, ED prevalence was again 58%. Age and IIEF scores demonstrated a statistically significant (p < 0.05, n = 38) Pearson's correlation coefficient of 0.40, patients younger than 30 years had an ED prevalence of 72% (mean IIEF 13), whereas patients aged 30 years and older had an ED prevalence of 45% (mean IIEF 22). All treatment modalities had ED rates >30%: chemotherapy demonstrated the highest prevalence at 64% (mean IIEF 17), whereas radiation therapy had the lowest prevalence at 33% (mean IIEF 23). Conclusion: This study demonstrates that the prevalence of sexual dysfunction among male AYA patients undergoing treatment for cancer is high. AYA oncologists should discuss potential sexual health concerns when treating this population. The exact cause of ED (non-organic vs. organic) within this group should be explored further. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of Journal of Adolescent & Young Adult Oncology is the property of Mary Ann Liebert, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.